Pfizer and Johnson & Johnson were among the returning backers to support a $100m series C round for Reflexion Medical, which secured the Rise Fund as lead investor.
US-based medical equipment manufacturer Reflexion Medical secured $100m in a series C round yesterday that featured the respective corporate venturing units of pharmaceutical firms Pfizer and Johnson & Johnson.
Pfizer Venture Investments and Johnson & Johnson Innovation – JJDC invested alongside the Rise Fund, an impact investment fund managed by TPG Growth, which led the round.
T. Rowe Price, GT Healthcare Capital Partners, Sofinnova Partners, KCK Group and Venrock also participated in the series C round.
Reflexion Medical is working…
